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Abstract The 40 N-terminal amino acids of the 20 kDa antigen 
A2 from Brucella melitensis were sequenced and showed impor- 
tant similarities with 4 bacterioferritins. A monoclonal antibody 
raised against this antigen cross-reacted with Escherichia coli 
bacterioferritin. Hybridization of two sets of degenerate primers 
with B. melitensis HindIII-digested genomic DNA identified a 3.8 
kb fragment. This fragment was shown to contain a bacteriofer- 
ritin gene (bfr) encoding a 161-amino acid protein. The sequence 
of the Brucella bacterioferritin is 69% similar to that of E. coli, 
and many of the ferroxidase centre and haem-ligation residues 
are conserved. 
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1. Introduction 
Iron is an essential element but can be toxic in excess, and 
most micro-organisms have developed transport and storage 
systems for the uptake and the deposition of this element in an 
intracellular non-toxic form. Brucella spp., the agents of brucel- 
losis, are intracellular facultative pathogens for which a corre- 
lation between iron metabolism and virulence has been postu- 
lated [1,2]. The acquisition of iron by the B. abortus iderophore 
(2,3-dihydroxybenzoic a id) has been the subject of a recent 
study [3], but no iron storage system has yet been reported. 
Recently, Zygmunt et al. [4] purified a 20 kDa protein previ- 
ously described as antigen A2 [5,6]. Six of the seven N-terminal 
residues of this protein are identical to six of the seven N- 
terminal residues of Nitrobacter winogradskyi bacterioferritin 
(BFR) [7] and five are identical to five of the seven N-terminal 
residues of Escherichia coli BFR [8]. BFR is an iron storage 
haemoprotein composed of 24 subunits assembled into a spher- 
ical protein shell containing approximately 12 haems per 24 
subunits [9-11] and has been detected in many species [12-16]. 
In this paper, we report cross-reaction of a monoclonal anti- 
body raised against the 20 kDa A2 antigen with E. coli BFR, 
the N-terminal amino acid sequencing of the 40 first residues 
of the protein (antigen A2), and the cloning of the bfr gene of 
B. melitensis 16M strain as well as its complete nucleotide 
sequence. 
*Corresponding author. Fax: (32) (81) 724 420. 
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2. Materials and methods 
2.1. Bacterial strain 
All whole-cell extracts of Brucella strains were prepared by J.-M. 
Verger and M. Grayon, lnstitut National de la Recherche 
Agronomique, Laboratoire de Pathologie Infectieuse t d'Immunolo- 
gie, Nouzilly, France. Briefly, cell lysis was achieved by boiling in the 
presence of 1% sodium dodecyl sulfate (SDS). 
2.2. Preparation of the 20 kDa antigen 
The B. melitensis 20 kDa protein (antigen A2) was prepared as 
previously described [4]. Briefly, a cytoplasmic protein extract from 
B. melitensis was fractionated by HiLoad Superdex 200 chromatogra- 
phy and the fractions containing the 20 kDa protein were separated by 
SDS-PAGE followed by electroelution f the 20 kDa protein from the 
gel. 
2.3. Monoclonal antibodies (mAbs) and antiserum 
BALB/c mice were immunized by 2 intraperitoneal injections of 200 
/lg of 20 kDa protein in Freund's complete adjuvant given 1 week apart. 
After 2 months, mice were boosted intraperitoneally with 200 ¢tg of the 
20 kDa protein. Three days after the boost injection, spleen cells were 
fused, as previously described [17], and hybridomas producing anti-20 
kDa mAbs were screened by immunoblotting using cytosoluble protein 
extract as antigen [18]. Among the positive clones, the Z297C3 clone 
was selected and ascitic fluid was produced in BALB/c mice as previ- 
ously described [19]. 
Anti-E. coli BFR serum was provided by S.C. Andrews (The Krebs 
Institute, Department of Molecular Biology and Biotechnology, Uni- 
versity of Sheffield, Sheffield, UK). 
2.4. N-Terminal sequence analysis" 
Edman recurrent degradation was performed on an automated step- 
wise sequencer with an on-line 120A phenylthiohydantoin a alyzer 
(Applied Biosystems). The sample was first desalted by reverse-phase 
HPLC on a 7-,urn 300A Aquapore RP 300 column (Brownlee). 
2.5. SDS-PA GE analysis and immunoblotting 
Recombinant E. coli BFR was provided by S.C. Andrews and was 
prepared as previously described [20]. Proteins were separated in 16% 
acrylamide SDS-PAGE slab gels and were then either stained with 
Coomasie brilliant blue or transferred electrophoretically to 0.2-/1m 
pore-size nitrocellulose for immunoblotting. Immunoblotting with 
mAb Z297C3 and anti-E, cob BFR serum was performed as previously 
described [211 . 
2.6. Recombinant DNA techniques 
Routine recombinant DNA techniques were performed according to 
Sambrook et al. [22]. Escherichia coli XLl-blue strain (Strat~,gene) was 
used as tile host for recombinant plasmids. Restriction endonucleases 
and modifying enzymes (Boehringer) were used as described by the 
manufacturer. 
Brucella melitensis 16M strain genomic DNA was obtained from 
J.-M. Verger and M. Grayon. Oligonucleotides were synthesized at 
Eurogentec and were radiolabelled using T4 polynucleotide kinase 
(Boehringer) and D'-32p]ATP (Amersham). Southern blotting on posi- 
tively charged nylon membranes (Amersham) was performed with a 
Hybaid Vacuum Blotter (Biozym). 
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Sequencing was performed using the Sequenase 2.0 kit (Pharmacia) 
according to the manufacturer's instructions. 
The nucleotide sequence data reported in this paper were submitted 
t~, GenBank and were assigned the accession umber U19760. 
2 7. DNA and protein sequence analysis 
Sequence data obtained from sequencing els were compiled and 
It nalyzed by the DNA Strider 1.2 program [23]. FastA, TFastA, Termi- 
I~ ator and Isoelectric programs were used with the Genetics Computer 
I ;roup Sequence Analysis Software Package version 8.0-OpenVMS or 
• 3-UNIX. The GenBank, EMBL and SWISS-PROT nucleic acid and 
1 rotein sequences databases were used for homology searches. The 
l acterioferritin sequences were analyzed with the Match-Box software 
t )r the simultaneous alignment of several protein sequences [24,25]. 
I Jsing this approach, a comparison of all 8-residues egments of se- 
t uence allows the analysis of similarity between and within groups of 
s,Nuences according to different statistical thresholds (cut-off dis- 
I races). 
, .  Results and discussion 
• 1. Western blot analysis of  the B. melitensis 20 kDa protein 
and E. coli bacterioferritin 
Immunoblot analysis with the anti-20 kDa mAb (Z297C3) 
ollowing SDS-PAGE of B. melitensis 16M strain whole-cell 
,~xtracts, purified 20 kDa protein, and E. coli recombinant BFR 
, rBFR) revealed cross-reaction of the anti-20 kDa mAb with 
~'. coli rBFR (Fig. 1). In the whole-cell extract, a band of higher 
['able 1 
r~rucella species, biovars and strains tested in immunoblotting with the 
mti-20 kDa protein mAb 
¢,pecies Biovar Strain 20-kDa protein 
detected 
~. abortus 1 544 + 
1 B19 + 
2 8618159 + 
3 Tulya + 
4 292 + 
5 B 3196 + 
6 870 + 
6 80-236 + 
6 89-43 + 
9 87-46 + 
9 90-64 + 
9 91-135 + 
9 76-299 + 
9 75-60 + 
9 80-133 + 
9 77-9 + 
9 C 68 + 
9 91-28 + 
Rough 45/20 + 
B. melitensis 1 16M + 
1 Rev 1 + 
2 63/9 + 
3 Ether + 
Rough B 115 + 
Rough H38R + 
B. suis 1 1330 + 
1 $2 + 
2 Tbomsen + 
3 686 + 
4 40 - 
5 513 - 
B. eanis RM 6/66 + 
B. ovis BOW 631290 + 
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14-  
Fig. 1. Immunoblot of B. melitensis whole-cell extract (lane 1 ), purified 
20 kDa protein (lane 2) and E. coli recombinant bacterioferritin with 
anti-20 kDa mAb Z297C3. Molecular weight (MW) markers are indi- 
cated on the left. 
molecular mass (38~,0 kDa) was detected• This band could 
consist of dimers of the 20 kDa protein. Though only very weak 
cross-reaction of anti-E, coli BFR serum was observed with the 
B. melitensis 20 kDa protein (data not shown), the above results 
indicate that the 20 kDa protein (antigen A2) could well be a 
bacterioferritin, as already suggested by the limited N-terminal 
sequence data. 
3.2. Expression of  the 20 kDa protein in the genus Brucella 
Thirty-four Brucella strains, including all six of the known 
species and all reported biovars, were examined for expression 
of the 20 kDa protein by SDS-PAGE and immunoblotting, as 
described above. The anti-20 kDa protein mAb revealed a band 
in all Brucella strains tested except for B. suis biovars 4 and 5 
(Table 1). These data indicate that the protein is expressed and 
that the apparent size of the antigen A2 (20-kDa protein) is 
identical among all strains except for B. suis biovars 4 and 5 for 
which no expression of the protein was detected. 
3.3. N-Terminal sequence analysis 
The sequence of the first 40 N-terminal residues of the 20 
kDa protein was obtained by automated Edman degradation, 
and is shown in Fig. 2. Sequence similarity searches were per- 
formed with the FastA algorithm and showed that this N- 
terminal sequence is very similar (45-65% identity) to the N- 
terminal sequences of seven bacterioferritins from the following 
strains: Nitrobacter winogradskyi [7], E. coli [8], Azotobacter 
vinelandii [26], Synechocystis spp. [13], Mycobacterium para- 
tuberculosis, M. avium, and M. leprae [14-16]. 
3.4. Cloning of  the bacterioferritin gene 
Two sets of degenerate primers were derived by back transla- 
tion of the N-terminal protein sequence, spanning residues 1 9 
(spld) and 23-31 (sp76d) (Fig. 2). 
Southern blot analysis of B. melitensis 16M strain HindIII 
digested genomic DNA with the radiolabelled sp 1 d set of prim- 
ers as probe, revealed hybridization of the primers with a 3.8 
kb band. Similar results were obtained with the sp76d probe set. 
The HindIII genomic DNA fragments of molecular weight 




M K G E P K V I E R L N 
ATGAARGGNGARCCNAARGTNATHGA 3' (spld)  
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A L F L E L G 
30 40 
A V N Q Y W L H Y R L L N D W G Y T R L 
5 ' AAYCARTAYTGGYTNCAYTAYAGRYA 3 ' ( sp76  d) 
Fig. 2. N-Terminal amino acid sequence of B. melitensis 20 kDa antigen A2 aligned with the nucleotide sequences ofthe corresponding degenerate 
primers used for cloning (R = A or G; Y -- C or T; H = A, C or T; N = A, C, G or T). 
an agarose gel and used to construct a partial genomic library 
of B. melitensis 16M strain in the vector pBluescript KS- .  
HindIII-digested plasmid DNA from the recombinant clones 
was analysed by Southern blotting with the radiolabelled spld 
set of primers as probe. One clone (pCm69) was shown to 
contain a plasmid which was positive in Southern and dot 
blotting (data not shown). 
3.5. DNA sequence analysis 
The recombinant plasmid pCm69 was used to determine the 
sequence of the B. melitensis bacterioferritin gene (Bm bfr). 
Sequencing was initiated with the sp76d set of primers and was 
further continued by the primer walking strategy. The nucleo- 
tide sequence of the Bm bfr gene as well as the amino acid 
sequence of the encoded protein are shown in Fig. 3. A 486 bp 
open reading frame (ORF) (positions 209 692) was identified. 
There is a potential Shine-Dalgarno ribosome-binding site 
(GGAG) from -12 to -9  bases upstream from the ATG, and 
a GC-rich region of dyad symmetry identified 20 bases down- 
stream from the stop codon could function as rho-independent 
transcription terminator [21]. 
Since Brucella genes are often expressed in E. coli from their 
own promoter, revealing a high degree of similarity to pub- 
lished E. coli promoters [21], a promoter search was performed 
using the Staden promoter prediction computer program [27]. 
There is a weakly predicted promoter at position 162 and a 
good predicted promoter at position 46. The expression of a 
number of E. coli genes concerned with iron uptake is known 
to be modulated with iron and this is, in many cases, mediated 
by the regulatory protein Fur [28]. As for the E. coli bfr gene, 
no iron box resembling the consensus sequence (GATAATGA- 
TAATCATTATC) was detected [29]. However, no Fur-like 
protein has been identified in Brucella and another egulation 
system is then conceivable. Moreover, in Brucella an uptake 
system in which only the siderophore is regulated by the iron 
available for growth has been suggested [3]. 
The deduced protein is a 161 amino acids peptide with a 
predicted molecular mass of 18,647 Da and a calculated pI of 
4.53; both values are in agreement with the experimental results 
obtained by Zygmunt et al. [4]. There is one difference between 
the N-terminal sequence obtained by Edman degradation and 
the deduced protein sequence (Glu-13 is in place of Asp-13 in 
the deduced protein sequence). 
> 100) to the BFR sequences of N. winogradskyi [7], E. coli 
[8], A. vinelandii [26], Synechocystis sp[13], M. paratuberculosis, 
M. avium, and M. leprae [14-16]. 
To investigate the extent of conserved and unconserved 
-35 -i0 ÷i 
1 AAGATTG CTGG CAA~ATTG TG CCG CGCTGTCTATAATGC CATGAATCA 
51 A CG CGGCCGTTGC'IX]TGGCTG CTTCCCAAATGTCGTAGAAACCATCATAA 
-35 
101 GGGTGACTGAA(~TACTATC"PTCGT OG CAACCAAATGGACGA~C~ 
-i0 +1 
151 TAA~ CAG~CATGGATCGTGTG CG~TCTC TACGAGATAAA~ 
1 M K G E P K V I E R L N D A 
201 TTCATGG;~%AAGGCGAAC CAAAGGTCAT CGAG CGGCTTAA CGATGCA 
15 L F L E L G A V N Q Y W L H Y R L 
251 CTGTTTCTTGAOCTCGGTG CGGTAAAC CAGTATTGGCTGCACTACCGTCT 
Sac I  
32  L N D W O Y T R L A K K E R E E S 
301 T CTCAACGATTGGGGqrPACACGCGCC'gTG CAAAGAAG GAACGC~AGGAAT 
49 I E E M H H A D K L I N R I I F 
351 C CATCGAGGAAATGCATCACG CC GA CAAG CTGATTAATCGCATTATCTT C 
65 F E G F P IV L Q T V S P L R I G Q 
401 T'I'PGAAGG CTTTC CGAA CCTCCAGACCGTqrPCG C C ~  CG CAq'I~GG CCA 
82 N V K E V L E A D L K G E Y D A R 
451 GAATGTOAAGGAAGT CTCGAAG CTGAC CAAGGGTGAATATGA CG CTC 
99 A S Y K E S R E I C D K L G D Y 
501 G CG ~ATAAGGAATCG CGCGAAATCTG CGACAAGCTCGG CGACTAT 
115 V S K Q L F D E L L A D E E G H I 
551 GTGTCGAAG CAGCTTTT CGACGAACTT CT GG CC GATGAAGAAGGC ATAT 
132 D F L E T Q L D L L A K I G E E R 
601 CGA CTTC CTTGAAAC CCAG CT CGAC CTTCTCGC CAAGATCGGCGAAGAAC 
149 Y G Q L IV A A P A D E A E * 
651 G CTATGG CCAG CTTAACGCGG CG CCCG CCGACGAAGCTGAG~G CCTGT 
701 TTCAATCTGTC' I~GAAAGGCGGGGG CGCATCG C T C C G G C A ~  
<<< << <(<<<< >>>>~> >> ~>> 
3.6. Multiple protein sequence analysis 
Similarities between the deduced Bm BFR amino acid se- 
quence and the sequences available in the databases were 
searched for with the FastA and TFastA algorithms. The Bm 
BFR sequence shows significant similarity (optimized score 
Fig. 3. Nucleotide sequence and deduced amino acid sequence of the 
bJf gene of B. melitensis and of the corresponding protein. The putative 
promoters are underlined. The putative ribosome-binding site is indi- 
cated in bold and boxed. The dyad symmetry of the putative terminator 
stem-loop structure is underlined (<<<>>>). The asterisk denotes the 
termination codon. 
1' A. Denoel et al./FEBS Letters 361 (1995) 238~42 241 
Brume 
Azovi 
Eco l i  
Mycav  
Myc le  
Syny3 
Mycpa 
N i tw i  
10 20 30 40 50 60 70 80 
I i • 
i * Q e • • 
90 iOO 110 120 130 140 150 160 
t * t 
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Syny3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Mycpa  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
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I'ig. 4. Simultaneous multiple alignment ofBFR sequences ofB. melitensis (Brume), A. vinelandii (Azovi), E. coli (Ecoli), M. avium (Mycav), M. Leprae 
VIycle), Synechocystis sp. (Syny3), M. paratuberculosis (Mycpa) and N. winogradskyi (Nitwi). Boxes delineate the matching regions. Black boxes 
, utline matching regions in the whole set of sequences (when sequences are complete) at a severe statistical threshold (400). Open boxes outline 
~ latching regions at a tolerant statistical threshold (520). Shaded boxes outline matching regions within groups of sequences ( tatistical thresh- 
, ld = 520). *Residues mentioned in the text. 
-equence regions between Bm BFR and these proteins, simulta- 
~eous multiple alignment was performed using the Match-Box 
~ackage [24,25] with the Blosum 62 amino acid substitution 
natr ix [30]. At a relatively severe statistical threshold (cut-off 
listance = 400), three boxes (black) are highlighted (Fig. 4). 
~hese boxes correspond to the most similar regions in all se- 
.luences. These regions enclose several totally conserved amino 
tcids and some of them are involved in the binuclear metal 
:~inding site [11]. For instance, Glu-51, Glu-127, and His-130 
tre fully conserved, and Glu-18 is replaced by a Gln in the 
kI, avium sequence. Two of the three residues directly involved 
n the haem binding site [11] (residues 26 and 52) are also 
:nclosed in these boxes. The third residue involved in the haem 
finding site, Asp-56, is enclosed in statistically similar regions 
lelineated at a tolerant threshold (open boxes, cut-off dis- 
ance = 520). Residues of the pseudo-twofold symmetry related 
mbunits described by Frolow [11] as having van der Waals 
:ontacts (<4 ,~) with haem are enclosed in boxes (except for 
%rg-45, Asp-56, and Leu-71) and are identical or very similar. 
The region comprising residues 98-118 appears to be the 
nost variable, as it can only be delineated at a very tolerant 
hreshold (cut-off distance = 585). This 98-118 variable region 
:orresponds to the end of the C helix, a loop and the beginning 
9f the D helix in the E. coli BFR [11,29], and does not contain 
-esidues of apparent importance for haem or iron binding. 
However, it is noteworthy that, within this highly variable re- 
gion, Asp- l l3  is the only residue to be fully conserved. 
The relevance of Brucella BFR as an antigen for purposes of 
diagnosis has not yet been explored in detail. However, antigen 
a,2 was originally identified with sera from infected ruminants 
14,6]. Therefore, BFR is an immunodominant B-cell antigen 
which could be used in a new brucellosis diagnostic test. 
Over-expression of the Bm BFR will enable us to provide 
functional evidence for the role of the protein and to estimate 
the number of haem per molecule. Regarding both the pro- 
posed involvement of BFR in the safe storage of iron and the 
importance of iron in the Brucella-macrophage interaction [2], 
and considering its identification and proposed significance in 
M. avium, another intracellular pathogen, it would be of inter- 
est to determine the role of the protein in the virulence of 
Brucella. 
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